Association of androgen receptor (AR) gene status in plasma DNA with outcome on enzalutamide in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Exploratory results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback